Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies

The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.

The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.

Parkinson's
Into the Light: A Profile of Joanne Chory
Into the Light: A Profile of Joanne Chory
Emily Makowski | Mar 1, 2020
The plant geneticist has revolutionized researchers’ understanding of how light affects plant growth and development, and is engineering plants to combat climate change.
The Best of Cell Biology
The Best of Cell Biology
Bob Grant | Dec 20, 2019
A new eBook compiles recent articles from The Scientist that capture the essence of new conceptual and technological territory being explored on the cellular level.
Neural Stem Cell Transplantation Crawls Toward the Clinic
Neural Stem Cell Transplantation Crawls Toward the Clinic
Ashley P. Taylor | Oct 29, 2019
Several early-stage clinical trials indicate that implanting patients with the cells is safe. But whether they can alleviate neurological problems remains to be seen.
Is It Time to Rethink Parkinson’s Pathology?
Is It Time to Rethink Parkinson’s Pathology?
Ashley Yeager | Oct 1, 2019
New evidence points to a waste-clearing problem in patients’ cells, rather than the accumulation of protein tangles, as the root cause of the neurodegenerative disease.
Infographic: Is Cellular Waste at the Root of Parkinson’s Disease?
Infographic: Is Cellular Waste at the Root of Parkinson’s Disease?
Ashley Yeager | Oct 1, 2019
Damage to the lysosome, the organelle that removes excess proteins, lipids, and other materials, might be at the root of the disease.
Mouse Model Shows How Parkinson’s Disease Begins in the Gut
Mouse Model Shows How Parkinson’s Disease Begins in the Gut
Emma Yasinski | Jun 26, 2019
Johns Hopkins’s Ted Dawson discusses his lab’s demonstration that misfolded α-synuclein can move from the stomach to the brain and cause physical and cognitive symptoms.
Chemicals on the Skin Could Enable Parkinson’s Detection
Chemicals on the Skin Could Enable Parkinson’s Detection
Shawna Williams | Mar 20, 2019
Researchers teamed up with a woman with a keen sense of smell to identify telling differences between healthy people and those with the neurodegenerative disease.
Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Katarina Zimmer | Nov 28, 2018
Since their discovery in 2006, induced pluripotent stem cells have been poised to reprogram regenerative medicine. Twelve years on, here’s how far they’ve come.
Randy Schekman to Leave <em>eLife</em>
Randy Schekman to Leave eLife
Kerry Grens | Aug 19, 2018
The founding editor-in-chief will redirect his focus to a Parkinson’s organization.